US20070167670A1 - Implantable cardiac assist device with a phased electrode array - Google Patents

Implantable cardiac assist device with a phased electrode array Download PDF

Info

Publication number
US20070167670A1
US20070167670A1 US11/539,763 US53976306A US2007167670A1 US 20070167670 A1 US20070167670 A1 US 20070167670A1 US 53976306 A US53976306 A US 53976306A US 2007167670 A1 US2007167670 A1 US 2007167670A1
Authority
US
United States
Prior art keywords
heart
pressure regulator
array
electrode array
apex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/539,763
Inventor
Edward Coleman
Gerard Coleman
William Neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/539,763 priority Critical patent/US20070167670A1/en
Assigned to COLEMAN, EDWARD J., DR. reassignment COLEMAN, EDWARD J., DR. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEILL, WILLIAM T., COLEMAN, GERARD T.
Publication of US20070167670A1 publication Critical patent/US20070167670A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20Type thereof
    • A61M60/247Positive displacement blood pumps
    • A61M60/253Positive displacement blood pumps including a displacement member directly acting on the blood
    • A61M60/268Positive displacement blood pumps including a displacement member directly acting on the blood the displacement member being flexible, e.g. membranes, diaphragms or bladders
    • A61M60/274Positive displacement blood pumps including a displacement member directly acting on the blood the displacement member being flexible, e.g. membranes, diaphragms or bladders the inlet and outlet being the same, e.g. para-aortic counter-pulsation blood pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/148Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/165Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
    • A61M60/191Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart mechanically acting upon the outside of the patient's native heart, e.g. compressive structures placed around the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20Type thereof
    • A61M60/289Devices for mechanical circulatory actuation assisting the residual heart function by means mechanically acting upon the patient's native heart or blood vessel structure, e.g. direct cardiac compression [DCC] devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/40Details relating to driving
    • A61M60/465Details relating to driving for devices for mechanical circulatory actuation
    • A61M60/468Details relating to driving for devices for mechanical circulatory actuation the force acting on the actuation means being hydraulic or pneumatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50Details relating to control
    • A61M60/508Electronic control means, e.g. for feedback regulation
    • A61M60/515Regulation using real-time patient data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3303Using a biosensor

Definitions

  • the present invention relates to therapeutic devices to work in conjunction with a diseased or failing heart to satisfy the hemodynamic needs of a patient. More particularly, the invention relates to a fully implantable device for assisting a heart to pump blood by intermittently applying pressure to at least a portion of the ventricular surface of the heart (if not the entire surface), preferably both the atrial and ventricular surfaces, at predetermined or possibly pre-programmed intervals to assist the heart to provide adequate hemodynamic output by sensing demand of the human body. In short, the present invention assists the maintenance of, or reestablishes, the normal contraction sequence of a healthy heart.
  • the present device is designed to restore to normal the electrical excitation pathways and mechanical contraction sequence of the failing heart. Where necessary, this restores the normal spread of electrical excitation pathways with a phased array electrical stimulation coupled with a phased array mechanical compression to restore the normal excitation/contraction sequence to a failing heart.
  • the human heart is a very complex organ that relies on both mechanical and electrical operation in order to perform properly.
  • problems can and often do arise, with the heart.
  • areas of the ventricle may lose their normal excitation pathways causing some parts of the ventricle to not contract when they are supposed to, losing, thereby, the circular compression and allowing some areas to “bulge.” This decreases efficiency.
  • These areas of heart muscle are intrinsically contracting mechanically, but lack the correct electrical input.
  • the muscle of the heart no longer contracts the ventricles to a sufficient extent. Insufficient ventricular contraction can produce a dangerous reduction in the amount of blood flow.
  • FIG. 6d and FIG. 7 illustrates an embodiment of the “Electrically-Controllable Multi-Fingered Resilient Heart Compression Device” disclosed therein.
  • artificial muscles specifically electro-active polymers, are used to create “soft fingers” that can be directly electrically powered and computer controlled by wires. See eg., U.S. Pat. No. 6,464,655 at column 8, lines 19-38,: The teachings of Shahinpoor are specifically incorporated by reference herein.
  • the present invention provides a fully implantable cardiac massage apparatus having a phased electrode array.
  • the cardiac massage apparatus of the invention can provide both “active” contraction of the heat, wherein the device electrically stimulates the heart to contract, or “passive” contraction of the heart, wherein the device squeezes the heart in a coordinated fashion so that the heart is massaged in a natural fashion from the apex to the base of the heart.
  • the cardiac massage apparatus comprises a chamber array, the array comprising a series or locus of spaced-apart, fluidically coupled, chambers or helices.
  • the array comprises helically-wound chambers, helices, or loops located closely adjacent or on the epicardium.
  • the array further has fluid input and output ports.
  • the chambers or helices collectively define an interior surface which closely conforms to the exterior surface of a heart when implanted.
  • the array can be comprised of a series of spaced apart chambers that are vertically oriented with respect to the heart.
  • the array fluid input port is located adjacent to the apex of the heart to be massaged and the fluid output port is located adjacent to the base of the heart to be massaged.
  • the cardiac massage apparatus also comprises a phased electrode array comprising a series of electrodes, the electrodes in contact with the heat and capable of providing electronic stimulation to the heart and capable of sensing cardiac output data of the heart.
  • the electrodes are located in the interior surface of the chambers of the chamber array, in another embodiment they are separate from the chambers of the chamber array.
  • the electrodes of the phased electrode array can also be connected to a phased electrode array controller means.
  • the phased electrode array controller means is an electronically-powered microprocessor and can be a separate component, or be integral to either the cardiac activity sensor/input means or a controller means for the chamber array.
  • the phased electrode array controller means controls the electrical discharge of the electrodes so that a coordinated electrical stimulation of the heart can be obtained to restore the hearts normal contraction sequence bringing about a normalization of the active phase of contraction
  • the cardiac massage apparatus of the present invention can also include coupled valve means, pump means, the chamber controller means, and the cardiac activity sensor/input means.
  • the valve means is fluidly or hydraulically coupled to the chamber array input port and output port and, in turn, is coupled to the pump means.
  • the pump means and valve means are both electronically coupled to the chamber controller means.
  • the chamber controller means is an electronically-powered microprocessor.
  • the chamber controller means of the present invention is adapted to actuate the pump means and valve means so that fluid is pumped substantially continuously through the input port while intermittently cycling the discharge. In this manner the fluidly-coupled chambers or helices are inflated and deflated starting at the apex of the heart and continuing toward the base of the heart to create a rhythmic cardiac massage which substantially imitates the natural contraction sequence of the heart.
  • a cardiac massage apparatus of the present invention further includes a cardiac activity sensor/input means which monitors or senses cardiac output.
  • the cardiac activity sensor/input means sends the cardiac output data to both the phased electrode array controller means and the chamber controller means.
  • the phased electrode array controller means and the chamber controller means can determine, based on preprogrammed parameters for cardiac output data, whether the cardiac massage apparatus needs to trigger either an “active” contraction of the heart by signaling the activation of the phased electrode array, or a “passive” contraction of the heart by having the chamber array contracting in a controlled fashion around the heart.
  • the massage apparatus can include a separately-implanted source of electrical energy such as, for example, a rechargeable battery and an optional fluid reservoir.
  • a separately-implanted source of electrical energy such as, for example, a rechargeable battery and an optional fluid reservoir.
  • FIG. 1 is a perspective view of one embodiment of an apparatus of the present invention.
  • FIG. 2 is a perspective view of a heart massage cup (or apparatus) of the present invention being inserted over a heart.
  • FIG. 3 is a perspective view of the heart massage apparatus of FIG. 2 in place on a heart.
  • FIG. 4 is a schematic view of the entire system implanted within the human body.
  • FIG. 5 is a schematic view in partial section, as a second embodiment of the present invention.
  • FIG. 6 shows the invention of FIG. 5 fully implanted within the human chest cavity.
  • FIG. 7 is a schematic view of another embodiment of the invention.
  • FIG. 8 is a cross-sectional representation of normally functioning heart before and after contraction.
  • FIG. 9 is a cross-sectional representation of an abnormally functioning heart before and after contraction.
  • the present invention provides a cardiac massage apparatus that provides assistance to a heart.
  • the cardiac massage apparatus does not interfere with the normal contraction pattern or rhythm of the heart as long as the “normal” pattern provides sufficient cardiac output of blood (e.g., from about 1.5 to about 3 liters per minute) to sustain and support the activities in which the patient wishes to engage.
  • blood e.g., from about 1.5 to about 3 liters per minute
  • the cardiac massage device can also “passively” contract the heart by mechanically or hydraulically contracting the heart by the contraction motion of a chambered array positioned around the heart. Such contraction is deemed “passive” as the heart is in a passive state, in that it is not contracting on its own, but contacts when acted on by the pumping action of the device. This hydraulic compression is done from the apex or tip of the heart to its base (or top) without abnormal compression of generally the middle portion of the heart.
  • FIG. 1 shows an embodiment of an apparatus or cardiac assist device 101 of the present invention.
  • a patient's heart 100 is shown schematically.
  • Enveloping or enshrouding heart 100 from its apex 102 to its base 104 is a helically wound length of tubing or a bladder array 106 , the tubing segments on the back side of heart 100 being shown in dashed lines.
  • the array 106 could comprise an arrangement, locus, or series of fluidically coupled chambers.
  • the heart-shaped cup member 202 is constituted of a somewhat rigid, but flexible material.
  • the material (preferably translucent) of cup-shaped member 202 should have adequate rigidity so that it does not collapse during diastolic actuation. Further, it should not expand radially to any great extent when pressurized fluid is introduced into chambers 108 in accordance with the method of the present invention.
  • This cup shaped member 202 provides a supporting envelope for efficiently assisting the mechanical compression of the heart 100 .
  • the cup 202 can apply substantially uniform fluid pressure against the exterior surface of at least a portion of the ventricular portion of the heart 100 during the systolic phase.
  • the cup 202 is designed to not unduly deform the natural shape of the heart 100 during the mechanical or hydraulic compression of the heart 100 .
  • the inside surface 210 of cup 202 in this embodiment, is in contact with the outer-most surface of chambers 108 so as to support them, to keep the segments or chambers separated from each other, and to direct inwardly (to compress heart 100 ) any pulsatile or pump surge input thereto.
  • the cup 202 can be installed in its operative position with minimal movement of the heart 100 .
  • the cup 202 can be sutured or otherwise attached to the heart 100 so as to prevent device migration during use.
  • a pressure regulator 110 and a pump 112 are shown in fluid communication with chamber array 106 .
  • the regulation of chamber pressure may be achieved by a relief valve coupled to the fluid circuit, a pressure regulator, or possibly, by “pump surge.”
  • Pressure regulator 110 and pump 112 are electrically coupled to a controller means or module 114 , e.g., a microprocessor. (Under circumstances where added complexity is permissible, a solenoid valve could be substituted for a pressure regulator 110 ).
  • Microprocessor 114 is programmed to receive input information as to the status and performance characteristics of heart 100 from a cardiac activity sensor/input means 115 .
  • the assist system shown in the FIG. 1 provides no stimulation or assistance to heart 100 .
  • microprocessor 114 receives input that the cardiac output of heart 100 is inadequate for the patient's activity and matches certain preprogrammed parameters that call for “passive” constriction, the microprocessor 114 activates pump 112 and valve 110 .
  • Pump 112 causes a fluid, preferably an incompressible, low viscosity, biocompatible fluid such as saline to flow into the individual helices 108 starting at the heart's apex 102 and flowing toward its base 104 .
  • a fluid preferably an incompressible, low viscosity, biocompatible fluid such as saline
  • saline a fluid, preferably an incompressible, low viscosity, biocompatible fluid such as saline to flow into the individual helices 108 starting at the heart's apex 102 and flowing toward its base 104 .
  • compressed gas could be used to activate the helices or chambers according to this invention.
  • This creates a wave form or wave front which travels from the apex toward the base which causes the heart (specifically the ventricles) to contract in rhythmic fashion. This contraction wave form tends to mimic normal cardiac depolarization but with enhanced or accelerated fluid blood flow from the ventricles.
  • the speed of pump 112 (which preferably is either a kinetic or centrifugal pump, a peristaltic or positive displacement pump but may be of any type including axial turbine or a radial pump) is coordinated with pressure regulator 110 to create a sequence or series of wave forms or pulses of fluid in chambers 108 causing at least the ventricles (but preferably both the ventricles and the atria) to be rhythmically massaged or compressed. In this manner cardiac output is substantially enhanced with the assistance of this device.
  • a device of this invention has the capability of assisting left and right ventricles (i.e., compressing or massaging) essentially simultaneously or sequentially.
  • the intensity of the compression step can be adjusted by adjusting pump speed and pressure regulator 110 timing.
  • the intensity of the compression step can also be adjusted by the selection of stiffness and diameter of the bladder or tube elements used to create the array 106 .
  • the number of chambers 108 wrapped around heart 100 and their separation distance also determines the intensity and extent of assist provided to the heart.
  • bladder characteristics may be needed to optimize the natural pumping efficiency of the heart using a device of this invention.
  • the cardiac assist device also contains a phased electrode array 490 having a series of electrodes 500 .
  • the electrodes 500 can be positioned on the interior (facing the heart) of the tubing array 106 as shown or can be placed adjacent the heart in other positions.
  • the electrodes 500 are electronically connected to a phased electrode array controller means 502 by means of wires 506 .
  • the electrodes can also be connected to a cardiac activity sensor/input means 115 .
  • the phased electrode array controller means 502 is suitably a microprocessor and is programmed to receive input information as to the status and performance characteristics of heart 100 .
  • the controller 502 can receive this information from feedback from the electrodes 500 themselves and/or from the cardiac activity sensor/input means 115 by way of the connection 504 .
  • the phased electrode controller means can be the same microprocessor (i.e. same part) used for the controller 114 for the tubing array, and can also be the same microprocessor as the sensing/input means. Assuming heart 100 is providing adequate cardiac output i.e., it is beating sufficiently frequently, with sufficient efficiency, the assist system shown in the FIG. 1 provides no stimulation or assistance to heart 100 .
  • phased electrode array controller means 502 receives input that the cardiac output of heart 100 is inadequate for the patient's activity and matches certain preprogrammed parameters that call for “active” contraction, the controller 502 electronically stimulates the appropriate electrodes 500 in the phased electrode array 490 to produce the desired contraction response, based on the cardiac output data received by the sensor/input means 115 .
  • physiological factor (or factors) observed or monitored by sensor/input means 115 to provide input to control means 114 may include many (if not all) of the parameters normally observed appurtenant to electrical sensing and/or pacing of the heart.
  • general body activity, oxygen saturation, pulse, peak-to-peak T-wave separation and numerous other indicia of cardiac activity may be observed in order to trigger e.g., via the microprocessor 114 , the use of the present device.
  • Appropriate input leads, whether internal or external to the heart, are selected depending upon the parameter(s) of cardiac activity selected to be observed or monitored.
  • the overall placement and configuration of the chamber array may be modified in view of the physiologic factor or factors chosen to be monitored.
  • the sensor/input means 115 can have sensors separate from the electrodes 500 that measure cardiac output i.e., blood flow or blood volume, directly.
  • cardiac output i.e., blood flow or blood volume
  • control means 114 could be the output from a cardiac pacemaker. Integration of the present device with a cardiac pacemaker would provide the advantage of e.g., fewer organ-electrode interfaces. It follows, of course, that a sophisticated pacemaker may control the pump and pressure regulator without the need for a second implanted control means (i.e., in the absence of control means 114 ).
  • the device shown in FIG. 1 presumes the chambers are either attached to the outside of the heart (e.g., by suturing) or placed within a semi-rigid cup such as is that shown and as also is depicted in U.S. Pat. No. 5,169,381, the teaching of which is incorporated by reference herein.
  • a mesh or net arrangement may be used in this latter embodiment.
  • the individual chambers 108 would be attached or retained on the inside surface of the cup so as to maintain the relative separation d, d′ between the chambers themselves while maintaining the chambers in contact with the heart's surface.
  • the cup or mesh arrangement also causes all expansion of helices 108 to be inwardly directed to create the advantageous bottom-to-top cardiac massage contemplated by this invention.
  • arrows 120 show the general direction of incompressible fluid flow within the system. As is shown, fluid leaves pump 112 passes toward the apex of the heart and then passes through the system toward the heart's base or basal region. It is this direction and the pulse effect given to the fluid via the use of pressure regulator 110 which creates the advantageous cardiac compression wave form which provides the unique cardiac assist of the present invention.
  • FIGS. 2 and 3 there is shown an embodiment to the present invention in which a heart-shaped cup member 202 is employed exteriorly of the chamber array 101 discussed above.
  • the exterior cup is used to anchor the individual chambers 108 and to maintain their separation distance d, d′.
  • cup member 202 is merely inserted over the heart 100 and sutured into place.
  • cup member 202 substantially envelopes heart 100 so as to maintain the chamber members 108 in exterior contact with the heart. Partial or complete coverage of heart 100 are both contemplated.
  • the heart is massaged or compressed in the advantageous fashion described herein thereby generating additional cardiac output.
  • FIG. 4 shows a fully implanted version of the present assist device 201 .
  • an additional implanted source of electrical energy e.g., a battery 203 and an implanted fluid reservoir 205 .
  • battery 203 is electrically coupled to pump 112 and, preferably the chamber controller 114 and the phased electrode array controller 502 while optional fluid reservoir 205 is fluidically coupled to pump 112 to replenish fluid to be pumped through the device 201 .
  • optional fluid reservoir 205 e.g., a larger diameter chamber array which would contain sufficient fluid, are within the contemplation of the present invention and will be readily apparent to one skilled in this art.
  • FIG. 5 shows schematically, a further embodiment of the present invention in which the chamber array 300 comprises a series of fingers or elongated patches 302 directed around the heart in a palm-open upward fashion.
  • the fingers or patches 302 are sutured to the exterior of heart 100 .
  • Chamber array 300 envelopes heart 100 such that when compressed radially inwardly e.g., by generation of a pulsatile wave or wave form, heart 100 is massaged or compressed in accordance with the invention.
  • Surrounding and enveloping fingers 302 is cup-shaped member 304 .
  • Member 304 is substantially radially rigid such that expansion of fingers 302 by pulsatile input of fluid from pump 112 (via input tubes or input connectors 308 ) causes fingers 302 (or at least the inside surface thereof 303 ) to be displaced inwardly arrow 305 thereby compress heart 100 . Fluid flows from the apex of heart 100 toward its base, pulsatile fluid emerging from fingers 302 into return connector or output connectors 310 to be returned to pressure regulator 110 for reuse. The outside surface 305 of finger 302 is in substantial contact with the inside surface 307 of member 304 .
  • FIG. 5 also shows the phased electrode array where the electrodes 500 are located on the patches 302 of the chamber array 300 , the electrodes 500 being adjacent to the heart. The electrodes 500 are connected by wires 506 to the phased electrode array controller 502 , which is in turn connected to the sensor/input means 115 .
  • FIG. 6 shows the embodiment of the invention of FIG. 5 , discussed above, fully implanted within the human chest cavity 42 . It should be noted that the devices shown in FIG. 4 and FIG. 6 are not necessarily drawn to the same scale.
  • FIG. 7 shows schematically, a further embodiment of the present invention in which the chamber array 400 comprises a series of “Bourdon type” fingers or elongated patches 402 directed around the heart in a palm-open upward fashion.
  • Bourdon fingers are made from an elastic material to allow them to expand and contract.
  • the Bourdon type fingers 402 as shown, are sutured to the elastic cup 403 which is sutured to the exterior of heart 100 .
  • the Bourdon chamber array envelops heart 100 such that it compresses the heart radially inward by straightening the fingers due to the pulsation of pressure inside the Bourdon tubes, massages the heart in accordance with the invention.
  • the cup-shaped elastic members 403 are substantially radially rigid and hence help the fingers 402 to compress the heart 100 effectively when pulsatile input of fluid from pump 112 (via pressure regulator valve 110 and input tube or input connector 408 ) cause the elastic fingers 402 to be displaced inwardly thereby massaging heart 100 .
  • the pressure generated due to the fluid flow from the pump 112 helps the heart to be massaged from the apex to its base in accordance with the invention.
  • pressure regulator 110 changes the direction of fluid flow upon the signal received from the microprocessor 114 , the backward fluid flow will contract the Bourdon tube fingers outwardly to release the pressure from the heart 100 .
  • Bourdon tubes are described in greater detail at pages 444 and 445 of Van Nostrand's Scientific Encyclopedia, 8th edition (1995), the entire description of which is incorporated by reference herein.
  • Bourdon tubes 402 have a lining with the electrodes 500 positioned in a phased array to be able to electrically stimulate/pace the heart in a specific time and location if indicated to get the heart to “actively” contract on its own as needed
  • the present invention has the advantage of providing cardiac assistance or enhancement without creating the kind of blood/device interfaces characteristic of artificial hearts, implanted blood pumps, and other such mechanical, fluid-circulating assist therapies.
  • blood/interface artifacts e.g., damage to blood constituents, thrombus creation, and coagulation do not result because the present invention uses only the normal cardiac endothelium to interface with blood.
  • the present invention is also broadly applicable to cardiac muscle infirmities which are evidenced by weakened cardiac muscle wall and muscle aneurysms or bulges. Such muscular infirmities are evidenced by dyskinetic cardiac muscle segments (i.e., wall segments which do not reliably contract, and hypokinetic segments i.e., wall segments which contract too slowly. Utilization of the present invention with its cardiac cupping or enveloping structure tends to mitigate or eliminate these phenomena.
  • the present invention is a method of mitigation of cardiac muscle infirmities including dyskinesia and hypokinesia, which method involves the steps of providing a heart-shaped, cup apparatus; deploying the cup apparatus so that it substantially envelopes a patient's heart evidencing muscle infirmities, the apparatus being located so as to provide exterior support thereto; and anchoring the cup apparatus to the patient's heart.

Abstract

The present invention provides a fully implantable cardiac massage apparatus having a phased electrode array. The cardiac massage apparatus of the invention can provide both “active” contraction of the heat, wherein the device electrically stimulates the heart to contract, or “passive” contraction of the heart, wherein the device squeezes the heart in a coordinated fashion so that the heart is massaged in a natural fashion from the apex to the base of the heart.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in-part application of U.S. patent application Ser. No. 10/829,573 filed Apr. 22, 2004, which claims priority to U.S. Provisional Patent Application Ser. No. 60/464,766, filed Apr. 23, 2003, the applications being incorporated herein by reference, in their entirety.
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • None
  • FIELD OF THE INVENTION
  • The present invention relates to therapeutic devices to work in conjunction with a diseased or failing heart to satisfy the hemodynamic needs of a patient. More particularly, the invention relates to a fully implantable device for assisting a heart to pump blood by intermittently applying pressure to at least a portion of the ventricular surface of the heart (if not the entire surface), preferably both the atrial and ventricular surfaces, at predetermined or possibly pre-programmed intervals to assist the heart to provide adequate hemodynamic output by sensing demand of the human body. In short, the present invention assists the maintenance of, or reestablishes, the normal contraction sequence of a healthy heart.
  • The present device is designed to restore to normal the electrical excitation pathways and mechanical contraction sequence of the failing heart. Where necessary, this restores the normal spread of electrical excitation pathways with a phased array electrical stimulation coupled with a phased array mechanical compression to restore the normal excitation/contraction sequence to a failing heart.
  • BACKGROUND OF THE INVENTION
  • The human heart is a very complex organ that relies on both mechanical and electrical operation in order to perform properly. As with any complex mechanism, problems can and often do arise, with the heart. For example, areas of the ventricle may lose their normal excitation pathways causing some parts of the ventricle to not contract when they are supposed to, losing, thereby, the circular compression and allowing some areas to “bulge.” This decreases efficiency. These areas of heart muscle are intrinsically contracting mechanically, but lack the correct electrical input. In addition, in some failing hearts the muscle of the heart no longer contracts the ventricles to a sufficient extent. Insufficient ventricular contraction can produce a dangerous reduction in the amount of blood flow.
  • Numerous attempts have been made to assist these diseased or failing hearts by applying external pressure directly to the heart. One such example is direct manual compression of the heart by a person's hand during open chest cardiopulmonary resuscitation. Often, however, the patient requires cardiac or circulatory support or assist for extended periods of time, such as hours, days, weeks, or for the rest of the patient's life. Thus, manual manipulation of the heart is not a solution to the problem in most cases.
  • Mechanical devices have been developed to apply external pressure directly to the heart. Some of these devices utilize an inflatable liner that surrounds the heart. For example, U.S. Pat. No. 5,119,804 Anstadt discloses a cup that is provided with an elastomeric liner. The heart is held in place within the liner, which is cyclically inflated and deflated to apply external pressure to the heart. While this device provides an improvement in hemodynamics for a diseased or failing heart, the device is not fully implantable. U.S. Pat. No. 5,131,905 Grooters and U.S. Pat. No. 6,238,334 Easterbrook, III et al. are further examples of external (as opposed to implantable) cardiac assist devices.
  • U.S. Pat. No. 6,464,655 Shahinpoor, at FIG. 6d and FIG. 7, illustrates an embodiment of the “Electrically-Controllable Multi-Fingered Resilient Heart Compression Device” disclosed therein. In the embodiment shown artificial muscles, specifically electro-active polymers, are used to create “soft fingers” that can be directly electrically powered and computer controlled by wires. See eg., U.S. Pat. No. 6,464,655 at column 8, lines 19-38,: The teachings of Shahinpoor are specifically incorporated by reference herein.
  • Another shortcoming inherent in the prior art devices results from the fact that relatively high pressures are applied almost exclusively to the central portion of the ventricles' outer surfaces. This causes the heart to deform into an unnatural, generally hourglass, shape and may even eventually cause trauma (e.g., bruises) to the heart, especially if one of the prior art devices is operated for an extended period of time.
  • SUMMARY OF THE INVENTION
  • The present invention provides a fully implantable cardiac massage apparatus having a phased electrode array. The cardiac massage apparatus of the invention can provide both “active” contraction of the heat, wherein the device electrically stimulates the heart to contract, or “passive” contraction of the heart, wherein the device squeezes the heart in a coordinated fashion so that the heart is massaged in a natural fashion from the apex to the base of the heart.
  • The cardiac massage apparatus comprises a chamber array, the array comprising a series or locus of spaced-apart, fluidically coupled, chambers or helices. In one embodiment the array comprises helically-wound chambers, helices, or loops located closely adjacent or on the epicardium. The array further has fluid input and output ports. The chambers or helices collectively define an interior surface which closely conforms to the exterior surface of a heart when implanted. In another embodiment the array can be comprised of a series of spaced apart chambers that are vertically oriented with respect to the heart. In one embodiment the array fluid input port is located adjacent to the apex of the heart to be massaged and the fluid output port is located adjacent to the base of the heart to be massaged.
  • The cardiac massage apparatus also comprises a phased electrode array comprising a series of electrodes, the electrodes in contact with the heat and capable of providing electronic stimulation to the heart and capable of sensing cardiac output data of the heart. In one embodiment the electrodes are located in the interior surface of the chambers of the chamber array, in another embodiment they are separate from the chambers of the chamber array. The electrodes of the phased electrode array can also be connected to a phased electrode array controller means. The phased electrode array controller means is an electronically-powered microprocessor and can be a separate component, or be integral to either the cardiac activity sensor/input means or a controller means for the chamber array. The phased electrode array controller means controls the electrical discharge of the electrodes so that a coordinated electrical stimulation of the heart can be obtained to restore the hearts normal contraction sequence bringing about a normalization of the active phase of contraction
  • The cardiac massage apparatus of the present invention can also include coupled valve means, pump means, the chamber controller means, and the cardiac activity sensor/input means. The valve means is fluidly or hydraulically coupled to the chamber array input port and output port and, in turn, is coupled to the pump means. The pump means and valve means are both electronically coupled to the chamber controller means. In one aspect, the chamber controller means is an electronically-powered microprocessor. The chamber controller means of the present invention is adapted to actuate the pump means and valve means so that fluid is pumped substantially continuously through the input port while intermittently cycling the discharge. In this manner the fluidly-coupled chambers or helices are inflated and deflated starting at the apex of the heart and continuing toward the base of the heart to create a rhythmic cardiac massage which substantially imitates the natural contraction sequence of the heart.
  • A cardiac massage apparatus of the present invention further includes a cardiac activity sensor/input means which monitors or senses cardiac output. The cardiac activity sensor/input means sends the cardiac output data to both the phased electrode array controller means and the chamber controller means. Depending on the cardiac output data, the phased electrode array controller means and the chamber controller means can determine, based on preprogrammed parameters for cardiac output data, whether the cardiac massage apparatus needs to trigger either an “active” contraction of the heart by signaling the activation of the phased electrode array, or a “passive” contraction of the heart by having the chamber array contracting in a controlled fashion around the heart.
  • In a further embodiment, the massage apparatus can include a separately-implanted source of electrical energy such as, for example, a rechargeable battery and an optional fluid reservoir.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Some of the features and advantages of the invention having briefly been stated, others will appear from the detailed description which follows, when taken in connection with the accompanying drawings in which:
  • FIG. 1 is a perspective view of one embodiment of an apparatus of the present invention.
  • FIG. 2 is a perspective view of a heart massage cup (or apparatus) of the present invention being inserted over a heart.
  • FIG. 3 is a perspective view of the heart massage apparatus of FIG. 2 in place on a heart.
  • FIG. 4 is a schematic view of the entire system implanted within the human body.
  • FIG. 5 is a schematic view in partial section, as a second embodiment of the present invention.
  • FIG. 6 shows the invention of FIG. 5 fully implanted within the human chest cavity.
  • FIG. 7 is a schematic view of another embodiment of the invention.
  • FIG. 8 is a cross-sectional representation of normally functioning heart before and after contraction.
  • FIG. 9 is a cross-sectional representation of an abnormally functioning heart before and after contraction.
  • Before the embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangements of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments and of being practiced or being carried out in various ways. Also, it is understood that the phraseology and terminology used herein are for the purpose of description and should not be regarded as limiting. The use of “including”, “having” and “comprising” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items and equivalents thereof.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention provides a cardiac massage apparatus that provides assistance to a heart. The cardiac massage apparatus does not interfere with the normal contraction pattern or rhythm of the heart as long as the “normal” pattern provides sufficient cardiac output of blood (e.g., from about 1.5 to about 3 liters per minute) to sustain and support the activities in which the patient wishes to engage. As shown in FIG. 8, when a heart is functioning normally, all areas of the heart contract at the same time. Before contraction (at a time T0) the internal area (a=x) of the heart is larger by half than the internal area (a=2/x) of the heart during contraction (at a time T1). However, when areas of a heart do not receive the proper electrical impulse to contract (as shown in FIG. 9), when the properly functioning areas of the heart contract it causes the heart to bulge around the “malfunctioning” area. In this instance internal area (a=x) of the heart during contraction (at a time T1) is approximately the same as the internal area of the heart (a=x) in an uncontracted state. Such a situation does not provide the necessary cardiac output of blood to the body. In such situations the present device provides cardiac assist by increasing blood flow by either mechanically contracting the heart or electronically stimulating it. Active contraction of the heart is done by causing the heart muscle itself to contract by electrically stimulating the heart by the use of a phased electrode array. This coordinated stimulation can be done to stimulate specific areas of the heart muscle that need to be stimulated, as determined by a sensing means, to provide the desired pumping action. The cardiac massage device can also “passively” contract the heart by mechanically or hydraulically contracting the heart by the contraction motion of a chambered array positioned around the heart. Such contraction is deemed “passive” as the heart is in a passive state, in that it is not contracting on its own, but contacts when acted on by the pumping action of the device. This hydraulic compression is done from the apex or tip of the heart to its base (or top) without abnormal compression of generally the middle portion of the heart.
  • One embodiment of the present invention is shown in FIG. 1. FIG. 1 shows an embodiment of an apparatus or cardiac assist device 101 of the present invention. A patient's heart 100 is shown schematically. Enveloping or enshrouding heart 100 from its apex 102 to its base 104 is a helically wound length of tubing or a bladder array 106, the tubing segments on the back side of heart 100 being shown in dashed lines. Alternatively, the array 106 could comprise an arrangement, locus, or series of fluidically coupled chambers. The individual helices 108 of the tubing array 106 shown in FIG. 1 are separated by distances d and d′: Distances d, d′ are variable and can be adjusted by the physician (e.g., by selecting a device with wider or narrower “d” spacing) to create a more natural mimic of the heart's rhythmic contractions as is described below. Also shown in phantom in FIG. 1 is an optional heart-shaped, supporting cup or envelope 202. The heart-shaped cup member 202 is constituted of a somewhat rigid, but flexible material. The material (preferably translucent) of cup-shaped member 202 should have adequate rigidity so that it does not collapse during diastolic actuation. Further, it should not expand radially to any great extent when pressurized fluid is introduced into chambers 108 in accordance with the method of the present invention. This cup shaped member 202 provides a supporting envelope for efficiently assisting the mechanical compression of the heart 100. The cup 202 can apply substantially uniform fluid pressure against the exterior surface of at least a portion of the ventricular portion of the heart 100 during the systolic phase. The cup 202 is designed to not unduly deform the natural shape of the heart 100 during the mechanical or hydraulic compression of the heart 100. As is shown in FIG. 1, the inside surface 210 of cup 202, in this embodiment, is in contact with the outer-most surface of chambers 108 so as to support them, to keep the segments or chambers separated from each other, and to direct inwardly (to compress heart 100) any pulsatile or pump surge input thereto. The cup 202 can be installed in its operative position with minimal movement of the heart 100. Suitably the cup 202 can be sutured or otherwise attached to the heart 100 so as to prevent device migration during use.
  • Also shown in FIG. 1 to be in fluid communication with chamber array 106 are a pressure regulator 110 and a pump 112. The regulation of chamber pressure may be achieved by a relief valve coupled to the fluid circuit, a pressure regulator, or possibly, by “pump surge.” Pressure regulator 110 and pump 112 are electrically coupled to a controller means or module 114, e.g., a microprocessor. (Under circumstances where added complexity is permissible, a solenoid valve could be substituted for a pressure regulator 110). Microprocessor 114 is programmed to receive input information as to the status and performance characteristics of heart 100 from a cardiac activity sensor/input means 115. Assuming heart 100 is providing adequate cardiac output i.e., it is beating sufficiently frequently, with sufficient efficiency, the assist system shown in the FIG. 1 provides no stimulation or assistance to heart 100. However when microprocessor 114 receives input that the cardiac output of heart 100 is inadequate for the patient's activity and matches certain preprogrammed parameters that call for “passive” constriction, the microprocessor 114 activates pump 112 and valve 110.
  • Pump 112 causes a fluid, preferably an incompressible, low viscosity, biocompatible fluid such as saline to flow into the individual helices 108 starting at the heart's apex 102 and flowing toward its base 104. (It is conceivable that compressed gas could be used to activate the helices or chambers according to this invention). This creates a wave form or wave front which travels from the apex toward the base which causes the heart (specifically the ventricles) to contract in rhythmic fashion. This contraction wave form tends to mimic normal cardiac depolarization but with enhanced or accelerated fluid blood flow from the ventricles. The speed of pump 112 (which preferably is either a kinetic or centrifugal pump, a peristaltic or positive displacement pump but may be of any type including axial turbine or a radial pump) is coordinated with pressure regulator 110 to create a sequence or series of wave forms or pulses of fluid in chambers 108 causing at least the ventricles (but preferably both the ventricles and the atria) to be rhythmically massaged or compressed. In this manner cardiac output is substantially enhanced with the assistance of this device. A device of this invention has the capability of assisting left and right ventricles (i.e., compressing or massaging) essentially simultaneously or sequentially.
  • The intensity of the compression step can be adjusted by adjusting pump speed and pressure regulator 110 timing. The intensity of the compression step can also be adjusted by the selection of stiffness and diameter of the bladder or tube elements used to create the array 106. The number of chambers 108 wrapped around heart 100 and their separation distance (discussed above), also determines the intensity and extent of assist provided to the heart. One skilled in the art will appreciate that some amount of experimentation regarding bladder characteristics may be needed to optimize the natural pumping efficiency of the heart using a device of this invention.
  • The cardiac assist device also contains a phased electrode array 490 having a series of electrodes 500. The electrodes 500 can be positioned on the interior (facing the heart) of the tubing array 106 as shown or can be placed adjacent the heart in other positions. The electrodes 500 are electronically connected to a phased electrode array controller means 502 by means of wires 506. In one embodiment the electrodes can also be connected to a cardiac activity sensor/input means 115. To aid in the clarity of the drawing the wires 506 to only a few of the electrodes 500 are shown, though all the electrodes have such wires. The phased electrode array controller means 502 is suitably a microprocessor and is programmed to receive input information as to the status and performance characteristics of heart 100. The controller 502 can receive this information from feedback from the electrodes 500 themselves and/or from the cardiac activity sensor/input means 115 by way of the connection 504. In another embodiment, the phased electrode controller means can be the same microprocessor (i.e. same part) used for the controller 114 for the tubing array, and can also be the same microprocessor as the sensing/input means. Assuming heart 100 is providing adequate cardiac output i.e., it is beating sufficiently frequently, with sufficient efficiency, the assist system shown in the FIG. 1 provides no stimulation or assistance to heart 100. However when phased electrode array controller means 502 receives input that the cardiac output of heart 100 is inadequate for the patient's activity and matches certain preprogrammed parameters that call for “active” contraction, the controller 502 electronically stimulates the appropriate electrodes 500 in the phased electrode array 490 to produce the desired contraction response, based on the cardiac output data received by the sensor/input means 115.
  • It also is to be appreciated that the physiological factor (or factors) observed or monitored by sensor/input means 115 to provide input to control means 114 may include many (if not all) of the parameters normally observed appurtenant to electrical sensing and/or pacing of the heart. Thus general body activity, oxygen saturation, pulse, peak-to-peak T-wave separation and numerous other indicia of cardiac activity may be observed in order to trigger e.g., via the microprocessor 114, the use of the present device. Appropriate input leads, whether internal or external to the heart, are selected depending upon the parameter(s) of cardiac activity selected to be observed or monitored. To some extent, the overall placement and configuration of the chamber array may be modified in view of the physiologic factor or factors chosen to be monitored.
  • It is possible that the sensor/input means 115 can have sensors separate from the electrodes 500 that measure cardiac output i.e., blood flow or blood volume, directly. Various sensors e.g., cardiac sensing/pacing leads, which measure cardiac output directly or indirectly, are available from Medtronic, Inc., in Fridley, Minn., U.S.A. Cardiac output also can be measured using a sensor inserted into an artery at the wrist.
  • It also is within the contemplation of this invention that the input 115 to control means 114 could be the output from a cardiac pacemaker. Integration of the present device with a cardiac pacemaker would provide the advantage of e.g., fewer organ-electrode interfaces. It follows, of course, that a sophisticated pacemaker may control the pump and pressure regulator without the need for a second implanted control means (i.e., in the absence of control means 114).
  • It is understood that the device shown in FIG. 1 presumes the chambers are either attached to the outside of the heart (e.g., by suturing) or placed within a semi-rigid cup such as is that shown and as also is depicted in U.S. Pat. No. 5,169,381, the teaching of which is incorporated by reference herein. Alternatively, a mesh or net arrangement (not shown) may be used in this latter embodiment. The individual chambers 108 would be attached or retained on the inside surface of the cup so as to maintain the relative separation d, d′ between the chambers themselves while maintaining the chambers in contact with the heart's surface. The cup or mesh arrangement also causes all expansion of helices 108 to be inwardly directed to create the advantageous bottom-to-top cardiac massage contemplated by this invention.
  • Referring to FIG. 1 arrows 120 show the general direction of incompressible fluid flow within the system. As is shown, fluid leaves pump 112 passes toward the apex of the heart and then passes through the system toward the heart's base or basal region. It is this direction and the pulse effect given to the fluid via the use of pressure regulator 110 which creates the advantageous cardiac compression wave form which provides the unique cardiac assist of the present invention.
  • Referencing FIGS. 2 and 3 there is shown an embodiment to the present invention in which a heart-shaped cup member 202 is employed exteriorly of the chamber array 101 discussed above. In this version of cardiac assist device 201 the exterior cup is used to anchor the individual chambers 108 and to maintain their separation distance d, d′. In this version of the invention cup member 202 is merely inserted over the heart 100 and sutured into place. As is shown in FIG. 3 cup member 202 substantially envelopes heart 100 so as to maintain the chamber members 108 in exterior contact with the heart. Partial or complete coverage of heart 100 are both contemplated. Thus, when fluid is pulsed into the helices of the present invention the heart is massaged or compressed in the advantageous fashion described herein thereby generating additional cardiac output.
  • FIG. 4 shows a fully implanted version of the present assist device 201. In addition to the components of the invention shown in FIG. 1 (and which similar designations have been used) there is shown an additional implanted source of electrical energy, e.g., a battery 203 and an implanted fluid reservoir 205. As is shown battery 203 is electrically coupled to pump 112 and, preferably the chamber controller 114 and the phased electrode array controller 502 while optional fluid reservoir 205 is fluidically coupled to pump 112 to replenish fluid to be pumped through the device 201. Equivalents to optional fluid reservoir 205, e.g., a larger diameter chamber array which would contain sufficient fluid, are within the contemplation of the present invention and will be readily apparent to one skilled in this art.
  • FIG. 5 shows schematically, a further embodiment of the present invention in which the chamber array 300 comprises a series of fingers or elongated patches 302 directed around the heart in a palm-open upward fashion. The fingers or patches 302, as shown, are sutured to the exterior of heart 100. Chamber array 300 envelopes heart 100 such that when compressed radially inwardly e.g., by generation of a pulsatile wave or wave form, heart 100 is massaged or compressed in accordance with the invention. Surrounding and enveloping fingers 302 is cup-shaped member 304. Member 304 is substantially radially rigid such that expansion of fingers 302 by pulsatile input of fluid from pump 112 (via input tubes or input connectors 308) causes fingers 302 (or at least the inside surface thereof 303) to be displaced inwardly arrow 305 thereby compress heart 100. Fluid flows from the apex of heart 100 toward its base, pulsatile fluid emerging from fingers 302 into return connector or output connectors 310 to be returned to pressure regulator 110 for reuse. The outside surface 305 of finger 302 is in substantial contact with the inside surface 307 of member 304. FIG. 5 also shows the phased electrode array where the electrodes 500 are located on the patches 302 of the chamber array 300, the electrodes 500 being adjacent to the heart. The electrodes 500 are connected by wires 506 to the phased electrode array controller 502, which is in turn connected to the sensor/input means 115.
  • FIG. 6 shows the embodiment of the invention of FIG. 5, discussed above, fully implanted within the human chest cavity 42. It should be noted that the devices shown in FIG. 4 and FIG. 6 are not necessarily drawn to the same scale.
  • FIG. 7 shows schematically, a further embodiment of the present invention in which the chamber array 400 comprises a series of “Bourdon type” fingers or elongated patches 402 directed around the heart in a palm-open upward fashion. Bourdon fingers are made from an elastic material to allow them to expand and contract. The Bourdon type fingers 402, as shown, are sutured to the elastic cup 403 which is sutured to the exterior of heart 100. The Bourdon chamber array envelops heart 100 such that it compresses the heart radially inward by straightening the fingers due to the pulsation of pressure inside the Bourdon tubes, massages the heart in accordance with the invention. The cup-shaped elastic members 403 are substantially radially rigid and hence help the fingers 402 to compress the heart 100 effectively when pulsatile input of fluid from pump 112 (via pressure regulator valve 110 and input tube or input connector 408) cause the elastic fingers 402 to be displaced inwardly thereby massaging heart 100. The pressure generated due to the fluid flow from the pump 112 helps the heart to be massaged from the apex to its base in accordance with the invention. When pressure regulator 110 changes the direction of fluid flow upon the signal received from the microprocessor 114, the backward fluid flow will contract the Bourdon tube fingers outwardly to release the pressure from the heart 100. The outflow of the fluid from the fingers 402 will return through the output connector 409 and pressure regulator valve 110) back into the pump 112 and reservoir 205 for reuse. Bourdon tubes are described in greater detail at pages 444 and 445 of Van Nostrand's Scientific Encyclopedia, 8th edition (1995), the entire description of which is incorporated by reference herein.
  • The Bourdon tube 402 arrangement is constructed to apply pressure in a coordinated and physiologic pattern about the heart in order to apply pressure to the needed location and timing sequence to aid the failing heart. A Bourdon tube 402 is a curved and partially flattened tube that tends to straighten out in proportion to thermal pressure. The unique feature of this is that the material properties of the Bourdon tube 402 in the non-pressurized state return to the “relaxed” or “non-compressive” state. Therefore when the Bourdon 402 tube is in a pressurized state from the input of fluid from pump 112, the tubes 402 contract the heart, and when they are not in a pressurized state, the tubes 402 recoil away from heart, facilitating the refilling of heart passively.
  • These Bourdon tubes 402 have a lining with the electrodes 500 positioned in a phased array to be able to electrically stimulate/pace the heart in a specific time and location if indicated to get the heart to “actively” contract on its own as needed
  • The present invention has the advantage of providing cardiac assistance or enhancement without creating the kind of blood/device interfaces characteristic of artificial hearts, implanted blood pumps, and other such mechanical, fluid-circulating assist therapies. Thus, blood/interface artifacts, e.g., damage to blood constituents, thrombus creation, and coagulation do not result because the present invention uses only the normal cardiac endothelium to interface with blood.
  • The present invention is also broadly applicable to cardiac muscle infirmities which are evidenced by weakened cardiac muscle wall and muscle aneurysms or bulges. Such muscular infirmities are evidenced by dyskinetic cardiac muscle segments (i.e., wall segments which do not reliably contract, and hypokinetic segments i.e., wall segments which contract too slowly. Utilization of the present invention with its cardiac cupping or enveloping structure tends to mitigate or eliminate these phenomena. Thus, in one aspect, the present invention is a method of mitigation of cardiac muscle infirmities including dyskinesia and hypokinesia, which method involves the steps of providing a heart-shaped, cup apparatus; deploying the cup apparatus so that it substantially envelopes a patient's heart evidencing muscle infirmities, the apparatus being located so as to provide exterior support thereto; and anchoring the cup apparatus to the patient's heart.
  • All patents, publications and references cited herein are hereby fully incorporated by reference. In the case of conflict between the present disclosure and the incorporated patents, publications and references, the present disclosure should control.
  • While the present invention has now been described and exemplified with some specificity, those skilled in the art will appreciate the various modifications, including variations, additions, and omissions that may be made in what has been described. Accordingly, it is intended that these modifications also be encompassed by the present invention and that the scope of the present invention be limited solely by the broadest interpretation that lawfully can be accorded the appended claims.

Claims (9)

1. An implantable cardiac massage apparatus for providing assistance to a heart having an apex and a base, the apparatus comprising:
a chamber array, the array comprising a series of spaced-apart, fluidically coupled chambers, the array having fluid input and output ports, wherein the input ports are located near the apex of the heart and the output ports are located near the base of the heart, and the chambers defining an inside surface which closely conforms to the external surface of a heart and;
pressure regulator means, the pressure regulator means being fluidly coupled to the array input port and output port, the pressure regulator means also being fluidically coupled to;
pump means, the pump means and the pressure regulator means being electronically coupled to;
controller means, the controller means being adapted to actuate the pump means and the pressure regulator means so that fluid is pumped substantially continuously by the pump means to the input port and the pressure regulator means intermittently inflates and deflates the chambers starting at the apex of the heart to create a rhythmic message of the heart from its apex to its base thereby substantially imitating the natural contraction of the heart, the controller means being further adapted to receive sensor information input from a cardiac activity/sensor means;
a phased electrode array comprising a series of electrodes, the electrodes in contact with the heart and capable of providing electronic stimulation to the heart;
a phased electrode array controller means, the phased electrode array controller means being adapted to control the discharge of electrical stimulation of the phased electrode array; and
wherein the cardiac activity/sensor means, the cardiac activity/sensor means being adapted to sense cardiac activity and input sensor information to the controller means and to input sensor information to the phased electrode array controller.
2. The apparatus of claim 1 which further includes an implantable reservoir means fluidly coupled to the chamber array.
3. The apparatus of claim 1 which further includes an implantable source of electrical energy electronically coupled to the pump means.
4. The apparatus of claim 1 electronically coupled to the controller means.
5. An apparatus of claim 1 wherein the pressure regulator means comprises a relief valve.
6. An apparatus of claim 1 wherein the pump means comprises a kinetic pump or axial turbine.
7. A method of mechanically assisting a heart comprising the steps of:
deploying an apparatus of claim 1 about the external surface of the heart;
activating the apparatus by energizing the controller means and in turn the pump means so as to cause fluid to flow through the apparatus;
pulsing fluid flow through the apparatus by operating the pressure regulator means the fluid flow starting at the apex of the heart and passing to the base of the heart thereby rhythmically massaging the heart from the apex toward its base to enhance the heart's fluid output in a manner similar to unassisted cardiac discharge.
8. An implantable cardiac massage apparatus for providing assistance to a heart having an apex and a base, the apparatus comprising:
a chamber array, wherein the chamber array comprises elastic Bourdon tubes, the array comprising a series of spaced-apart, fluidically coupled chambers the array having fluid input and output ports, and the chambers defining an inside surface which closely conforms to the external surface of a heart and;
pressure regulator means, the pressure regulator means being fluidly coupled to the array input port and output port, the pressure regulator means also being fluidically coupled to;
pump means, the pump means and the pressure regulator means being electronically coupled to;
controller means, the controller means being adapted to actuate the pump means and the pressure regulator means so that fluid is pumped by the pump means to the input port and the pressure regulator means intermittently inflates and deflates the chambers starting at the apex of the heart to create a rhythmic message of the heart from its apex to its base thereby substantially imitating the natural contraction of the heart, the controller means being further adapted to receive sensor information input from a cardiac activity/sensor means;
a phased electrode array comprising a series of electrodes, the electrodes in contact with the heart and capable of providing electronic stimulation to the heart;
a phased electrode array controller means, the phased electrode array controller means being adapted to control the discharge of electrical stimulation of the phased electrode array; and
wherein the cardiac activity/sensor means, the cardiac activity/sensor means being adapted to sense cardiac activity and input sensor information to the controller means and to input sensor information to the phased electrode array controller means.
9. An implantable cardiac massage apparatus for providing assistance to a heart having an apex and a base, the apparatus comprising:
a helically wound tubing formed into an array, the array having a fluid input port located near the apex of the heart and a fluid output port located near the base of the heart, and the array defining an inside surface which closely conforms to the external surface of a heart and;
pressure regulator means, the pressure regulator means being fluidly coupled to the array input port and output port, the pressure regulator means also being fluidically coupled to;
pump means, the pump means and the pressure regulator means being electronically coupled to;
controller means, the controller means being adapted to actuate the pump means and the pressure regulator means so that fluid is pumped substantially continuously by the pump means to the input port and the pressure regulator means intermittently inflates and deflates the helically wound tubing starting at the apex of the heart to create a rhythmic message of the heart from its apex to its base thereby substantially imitating the natural contraction of the heart, the controller means being further adapted to receive sensor information input from a cardiac activity/sensor means;
a phased electrode array comprising a series of electrodes, the electrodes in contact with the heart and capable of providing electronic stimulation to the heart;
a phased electrode array controller means, the phased electrode array controller means being adapted to control the discharge of electrical stimulation of the phased electrode array; and
wherein the cardiac activity/sensor means, the cardiac activity/sensor means being adapted to sense cardiac activity and input sensor information to the controller means and to input sensor information to the phased electrode array controller means.
US11/539,763 2003-04-23 2006-10-09 Implantable cardiac assist device with a phased electrode array Abandoned US20070167670A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/539,763 US20070167670A1 (en) 2003-04-23 2006-10-09 Implantable cardiac assist device with a phased electrode array

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46476603P 2003-04-23 2003-04-23
US10/829,573 US7118525B2 (en) 2003-04-23 2004-04-22 Implantable cardiac assist device
US11/539,763 US20070167670A1 (en) 2003-04-23 2006-10-09 Implantable cardiac assist device with a phased electrode array

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/829,573 Continuation-In-Part US7118525B2 (en) 2003-04-23 2004-04-22 Implantable cardiac assist device

Publications (1)

Publication Number Publication Date
US20070167670A1 true US20070167670A1 (en) 2007-07-19

Family

ID=33313497

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/829,573 Expired - Fee Related US7118525B2 (en) 2003-04-23 2004-04-22 Implantable cardiac assist device
US11/539,763 Abandoned US20070167670A1 (en) 2003-04-23 2006-10-09 Implantable cardiac assist device with a phased electrode array

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/829,573 Expired - Fee Related US7118525B2 (en) 2003-04-23 2004-04-22 Implantable cardiac assist device

Country Status (3)

Country Link
US (2) US7118525B2 (en)
CA (1) CA2564541A1 (en)
WO (1) WO2004093731A2 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010042022A1 (en) * 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
WO2010042012A1 (en) * 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
US20110196486A1 (en) * 2008-10-10 2011-08-11 Milux Holdings SA Heart help device, system, and method
US20110196192A1 (en) * 2008-10-10 2011-08-11 Milux Holding S.A. Heart help device, system, and method
US8096939B2 (en) 2000-02-10 2012-01-17 Obtech Medical Ag Urinary incontinence treatment with wireless energy supply
US8096938B2 (en) 1999-08-12 2012-01-17 Obtech Medical Ag Controlled anal incontinence disease treatment
US8126558B2 (en) 2000-02-14 2012-02-28 Obtech Medical Ag Controlled penile prosthesis
US8290594B2 (en) 2000-02-11 2012-10-16 Obtech Medical Ag Impotence treatment apparatus with energy transforming means
US8287444B2 (en) 2000-02-10 2012-10-16 Obtech Medical Ag Mechanical impotence treatment apparatus
US8313423B2 (en) 2000-02-14 2012-11-20 Peter Forsell Hydraulic anal incontinence treatment
US8545384B2 (en) 1999-08-12 2013-10-01 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US8556796B2 (en) 2000-02-10 2013-10-15 Obtech Medical Ag Controlled urinary incontinence treatment
US8600510B2 (en) 2008-10-10 2013-12-03 Milux Holding Sa Apparatus, system and operation method for the treatment of female sexual dysfunction
US8636809B2 (en) 2008-01-29 2014-01-28 Milux Holding Sa Device for treating obesity
US8678997B2 (en) 2000-02-14 2014-03-25 Obtech Medical Ag Male impotence prosthesis apparatus with wireless energy supply
US8734318B2 (en) 2000-02-11 2014-05-27 Obtech Medical Ag Mechanical anal incontinence
US8764627B2 (en) 2000-02-14 2014-07-01 Obtech Medical Ag Penile prosthesis
US8795150B2 (en) 2008-10-10 2014-08-05 Milux Holding S.A. Heart help device, system, and method
US8874215B2 (en) 2008-10-10 2014-10-28 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US8961448B2 (en) 2008-01-28 2015-02-24 Peter Forsell Implantable drainage device
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US10219898B2 (en) 2008-10-10 2019-03-05 Peter Forsell Artificial valve
US10952836B2 (en) 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
US11123171B2 (en) 2008-10-10 2021-09-21 Peter Forsell Fastening means for implantable medical control assembly

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850729B2 (en) 2002-07-18 2010-12-14 The University Of Cincinnati Deforming jacket for a heart actuation device
US7118525B2 (en) * 2003-04-23 2006-10-10 Coleman Edward J Implantable cardiac assist device
WO2004110553A1 (en) 2003-06-09 2004-12-23 The University Of Cincinnati Actuation mechanisms for a heart actuation device
US20060178551A1 (en) * 2003-06-09 2006-08-10 Melvin David B Securement system for a heart actuation device
US20060167334A1 (en) * 2003-06-26 2006-07-27 Anstadt Mark P Method and apparatus for direct mechanical ventricular actuation with favorable conditioning and minimal heart stress
US20050004419A1 (en) * 2003-07-03 2005-01-06 Jacob Lavee Hydraulic assist method and system
US20050148814A1 (en) * 2004-01-05 2005-07-07 Fischi Michael C. Muscle function augmentation
CA2635658A1 (en) * 2006-01-04 2007-07-12 Nanopowers S.A. Artificial contractile tissue
US20070185369A1 (en) * 2006-02-03 2007-08-09 Mahmood Mirhoseini Cardiac assist device and method
WO2007114905A2 (en) * 2006-04-04 2007-10-11 Gem Biosystems, Inc. Pericardial inserts and methods of use
US9656009B2 (en) * 2007-07-11 2017-05-23 California Institute Of Technology Cardiac assist system using helical arrangement of contractile bands and helically-twisting cardiac assist device
US20090177028A1 (en) * 2008-01-04 2009-07-09 Anthony John White Non-blood contact cardiac compression device, for augmentation of cardiac function by timed cyclic tensioning of elastic cords in an epicardial location
DE102009043795B4 (en) 2009-09-30 2017-10-19 AdjuCor GmbH Cardiac assist device and method for its control
US9125655B2 (en) 2010-07-16 2015-09-08 California Institute Of Technology Correction and optimization of wave reflection in blood vessels
US8795149B2 (en) * 2010-11-23 2014-08-05 Theodore J. Lillehei Pneumatic or hydraulic cardiac assist devices
DE102013200151A1 (en) 2013-01-08 2014-07-10 AdjuCor GmbH Heart support device with markings
US9220824B2 (en) 2013-01-08 2015-12-29 AdjuCor GmbH Implanting cardiac devices
DE102013200148A1 (en) * 2013-01-08 2014-07-10 AdjuCor GmbH Plug system for a cardiac assist device
WO2015051380A2 (en) * 2013-10-04 2015-04-09 President And Fellows Of Harvard College Biomimetic actuation device and system, and methods for controlling a biomimetic actuation device and system
WO2019130066A1 (en) * 2018-01-01 2019-07-04 Mahdi Daliri Rezagholi Gheshlaghi Twisting biventricular cardiac assist device (cardio twist)
WO2017223485A1 (en) * 2016-06-23 2017-12-28 The Texas A&M University System Fully implantable direct myocardium assist device
WO2018226991A1 (en) 2017-06-07 2018-12-13 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
WO2019094963A1 (en) 2017-11-13 2019-05-16 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
CN112004563A (en) 2018-02-01 2020-11-27 施菲姆德控股有限责任公司 Intravascular blood pump and methods of use and manufacture
DE102018208931A1 (en) * 2018-06-06 2019-12-12 Kardion Gmbh Apparatus for determining cardiac output for a cardiac assist system, cardiac assistive system and method for determining cardiac output
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP3771473A1 (en) 2019-07-29 2021-02-03 ETH Zurich Cardiac assist device
EP4034192A4 (en) 2019-09-25 2023-11-29 Shifamed Holdings, LLC Intravascular blood pump systems and methods of use and control thereof
IT202000015208A1 (en) * 2020-06-24 2021-12-24 Scuola Superiore Di Studi Univ E Di Perfezionamento Santanna ARTIFICIAL CARDIAC MUSCLE
US11383076B2 (en) 2020-10-01 2022-07-12 Lifebridge Technologies, Llc Pump regulation based on heart size and function
US11896812B1 (en) 2023-01-27 2024-02-13 Lifebridge Technologies Llc Versatile modular heart pump for non-blood contacting ventricular function augmentation

Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902291A (en) * 1989-01-31 1990-02-20 University Of Utah Research Foundation Collapsible artificial ventricle and pumping shell
US4957477A (en) * 1986-05-22 1990-09-18 Astra Tech Ab Heart assist jacket and method of using it
US5119804A (en) * 1990-11-19 1992-06-09 Anstadt George L Heart massage apparatus
US5131905A (en) * 1990-07-16 1992-07-21 Grooters Ronald K External cardiac assist device
US5169381A (en) * 1991-03-29 1992-12-08 Snyders Robert V Ventricular assist device
US5250167A (en) * 1992-06-22 1993-10-05 The United States Of America As Represented By The United States Department Of Energy Electrically controlled polymeric gel actuators
US5256132A (en) * 1992-08-17 1993-10-26 Snyders Robert V Cardiac assist envelope for endoscopic application
US5271746A (en) * 1991-03-20 1993-12-21 Clinique De La Residence Du Parc Implantable blood pump with inextensible deformable closed bag
US5273518A (en) * 1992-01-31 1993-12-28 Medtronic, Inc. Cardiac assist apparatus
US5389222A (en) * 1993-09-21 1995-02-14 The United States Of America As Represented By The United States Department Of Energy Spring-loaded polymeric gel actuators
US5397349A (en) * 1992-07-30 1995-03-14 University Of Utah Research Foundation Muscle and air powered LVAD
US5429584A (en) * 1990-11-09 1995-07-04 Mcgill University Cardiac assist method and apparatus
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US5713954A (en) * 1995-06-13 1998-02-03 Abiomed R&D, Inc. Extra cardiac ventricular assist device
US5738627A (en) * 1994-08-18 1998-04-14 Duke University Bi-ventricular cardiac assist device
US5749839A (en) * 1994-08-18 1998-05-12 Duke University Direct mechanical bi-ventricular cardiac assist device
US5800334A (en) * 1993-06-17 1998-09-01 Wilk; Peter J. Intrapericardial assist device and associated method
US5902229A (en) * 1998-03-30 1999-05-11 Cardio Technologies, Inc. Drive system for controlling cardiac compression
US5971911A (en) * 1993-06-17 1999-10-26 Wilk; Peter J. Intrapericardial assist device and associated method
US5971910A (en) * 1996-10-18 1999-10-26 Cardio Technologies, Inc. Method and apparatus for assisting a heart to pump blood by applying substantially uniform pressure to the ventricles
US6109852A (en) * 1996-01-18 2000-08-29 University Of New Mexico Soft actuators and artificial muscles
US6238334B1 (en) * 1997-11-03 2001-05-29 Cardio Technologies, Inc. Method and apparatus for assisting a heart to pump blood
US6254525B1 (en) * 1998-11-04 2001-07-03 Cardio Technologies, Inc. Cardiac assist system and method thereof
US6258021B1 (en) * 1993-06-17 2001-07-10 Peter J. Wilk Intrapericardial assist method
US6282445B1 (en) * 1998-10-15 2001-08-28 Cardio Technologies, Inc. Passive defibrillation electrodes for use with cardiac assist device
US6464655B1 (en) * 1999-03-17 2002-10-15 Environmental Robots, Inc. Electrically-controllable multi-fingered resilient heart compression devices
US6475639B2 (en) * 1996-01-18 2002-11-05 Mohsen Shahinpoor Ionic polymer sensors and actuators
US6602182B1 (en) * 2000-11-28 2003-08-05 Abiomed, Inc. Cardiac assistance systems having multiple fluid plenums
US7118525B2 (en) * 2003-04-23 2006-10-10 Coleman Edward J Implantable cardiac assist device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272746A (en) * 1992-02-05 1993-12-21 Genshi Nenryo Kogyo Kabushiki Kaisha Method of evaluating a degree of fatigue in a structural material

Patent Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957477A (en) * 1986-05-22 1990-09-18 Astra Tech Ab Heart assist jacket and method of using it
US4902291A (en) * 1989-01-31 1990-02-20 University Of Utah Research Foundation Collapsible artificial ventricle and pumping shell
US5131905A (en) * 1990-07-16 1992-07-21 Grooters Ronald K External cardiac assist device
US5429584A (en) * 1990-11-09 1995-07-04 Mcgill University Cardiac assist method and apparatus
US5119804A (en) * 1990-11-19 1992-06-09 Anstadt George L Heart massage apparatus
US5271746A (en) * 1991-03-20 1993-12-21 Clinique De La Residence Du Parc Implantable blood pump with inextensible deformable closed bag
US5169381A (en) * 1991-03-29 1992-12-08 Snyders Robert V Ventricular assist device
US5273518A (en) * 1992-01-31 1993-12-28 Medtronic, Inc. Cardiac assist apparatus
US5250167A (en) * 1992-06-22 1993-10-05 The United States Of America As Represented By The United States Department Of Energy Electrically controlled polymeric gel actuators
US5397349A (en) * 1992-07-30 1995-03-14 University Of Utah Research Foundation Muscle and air powered LVAD
US5256132A (en) * 1992-08-17 1993-10-26 Snyders Robert V Cardiac assist envelope for endoscopic application
US5800334A (en) * 1993-06-17 1998-09-01 Wilk; Peter J. Intrapericardial assist device and associated method
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US6258021B1 (en) * 1993-06-17 2001-07-10 Peter J. Wilk Intrapericardial assist method
US5971911A (en) * 1993-06-17 1999-10-26 Wilk; Peter J. Intrapericardial assist device and associated method
US5389222A (en) * 1993-09-21 1995-02-14 The United States Of America As Represented By The United States Department Of Energy Spring-loaded polymeric gel actuators
US5738627A (en) * 1994-08-18 1998-04-14 Duke University Bi-ventricular cardiac assist device
US5908378A (en) * 1994-08-18 1999-06-01 Duke University Bi-ventricular cardiac assist device
US5749839A (en) * 1994-08-18 1998-05-12 Duke University Direct mechanical bi-ventricular cardiac assist device
US5713954A (en) * 1995-06-13 1998-02-03 Abiomed R&D, Inc. Extra cardiac ventricular assist device
US6475639B2 (en) * 1996-01-18 2002-11-05 Mohsen Shahinpoor Ionic polymer sensors and actuators
US6109852A (en) * 1996-01-18 2000-08-29 University Of New Mexico Soft actuators and artificial muscles
US5971910A (en) * 1996-10-18 1999-10-26 Cardio Technologies, Inc. Method and apparatus for assisting a heart to pump blood by applying substantially uniform pressure to the ventricles
US6238334B1 (en) * 1997-11-03 2001-05-29 Cardio Technologies, Inc. Method and apparatus for assisting a heart to pump blood
US5902229A (en) * 1998-03-30 1999-05-11 Cardio Technologies, Inc. Drive system for controlling cardiac compression
US6282445B1 (en) * 1998-10-15 2001-08-28 Cardio Technologies, Inc. Passive defibrillation electrodes for use with cardiac assist device
US6254525B1 (en) * 1998-11-04 2001-07-03 Cardio Technologies, Inc. Cardiac assist system and method thereof
US6464655B1 (en) * 1999-03-17 2002-10-15 Environmental Robots, Inc. Electrically-controllable multi-fingered resilient heart compression devices
US6602182B1 (en) * 2000-11-28 2003-08-05 Abiomed, Inc. Cardiac assistance systems having multiple fluid plenums
US7118525B2 (en) * 2003-04-23 2006-10-10 Coleman Edward J Implantable cardiac assist device

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8096938B2 (en) 1999-08-12 2012-01-17 Obtech Medical Ag Controlled anal incontinence disease treatment
US8545384B2 (en) 1999-08-12 2013-10-01 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US8556796B2 (en) 2000-02-10 2013-10-15 Obtech Medical Ag Controlled urinary incontinence treatment
US8602966B2 (en) 2000-02-10 2013-12-10 Obtech Medical, AG Mechanical impotence treatment apparatus
US8287444B2 (en) 2000-02-10 2012-10-16 Obtech Medical Ag Mechanical impotence treatment apparatus
US8096939B2 (en) 2000-02-10 2012-01-17 Obtech Medical Ag Urinary incontinence treatment with wireless energy supply
US8734318B2 (en) 2000-02-11 2014-05-27 Obtech Medical Ag Mechanical anal incontinence
US8290594B2 (en) 2000-02-11 2012-10-16 Obtech Medical Ag Impotence treatment apparatus with energy transforming means
US8126558B2 (en) 2000-02-14 2012-02-28 Obtech Medical Ag Controlled penile prosthesis
US8313423B2 (en) 2000-02-14 2012-11-20 Peter Forsell Hydraulic anal incontinence treatment
US8764627B2 (en) 2000-02-14 2014-07-01 Obtech Medical Ag Penile prosthesis
US8678997B2 (en) 2000-02-14 2014-03-25 Obtech Medical Ag Male impotence prosthesis apparatus with wireless energy supply
US8961448B2 (en) 2008-01-28 2015-02-24 Peter Forsell Implantable drainage device
US20150157836A1 (en) * 2008-01-28 2015-06-11 Peter Mats Forsell Implantable drainage device
US9694165B2 (en) * 2008-01-28 2017-07-04 Peter Mats Forsell Implantable drainage device
US9060771B2 (en) 2008-01-29 2015-06-23 Peter Forsell Method and instrument for treating obesity
US8636809B2 (en) 2008-01-29 2014-01-28 Milux Holding Sa Device for treating obesity
US8696745B2 (en) 2008-10-10 2014-04-15 Kirk Promotion Ltd. Heart help device, system, and method
US20110196486A1 (en) * 2008-10-10 2011-08-11 Milux Holdings SA Heart help device, system, and method
US8509894B2 (en) 2008-10-10 2013-08-13 Milux Holding Sa Heart help device, system, and method
WO2010042022A1 (en) * 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
US8475355B2 (en) 2008-10-10 2013-07-02 Milux Holding S.A. Heart help device, system, and method
US8469874B2 (en) 2008-10-10 2013-06-25 Milux Holding Sa Heart help device, system, and method
US8795150B2 (en) 2008-10-10 2014-08-05 Milux Holding S.A. Heart help device, system, and method
US8874215B2 (en) 2008-10-10 2014-10-28 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US20110201871A1 (en) * 2008-10-10 2011-08-18 Milux Holding Sa Heart help device, system, and method
US9005104B2 (en) 2008-10-10 2015-04-14 Peter Forsell Heart help device, system, and method
US20110196192A1 (en) * 2008-10-10 2011-08-11 Milux Holding S.A. Heart help device, system, and method
US8600510B2 (en) 2008-10-10 2013-12-03 Milux Holding Sa Apparatus, system and operation method for the treatment of female sexual dysfunction
US9072907B2 (en) 2008-10-10 2015-07-07 Peter Forsell Heart help device, system, and method
US9370656B2 (en) 2008-10-10 2016-06-21 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US9526649B2 (en) 2008-10-10 2016-12-27 Peter Forsell Method and instrument for treating obesity
WO2010042012A1 (en) * 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
US11123171B2 (en) 2008-10-10 2021-09-21 Peter Forsell Fastening means for implantable medical control assembly
US10219898B2 (en) 2008-10-10 2019-03-05 Peter Forsell Artificial valve
US10583234B2 (en) 2008-10-10 2020-03-10 Peter Forsell Heart help device, system and method
US10668196B2 (en) 2008-10-10 2020-06-02 Peter Forsell Heart assisting device
US20200353139A1 (en) * 2008-10-10 2020-11-12 Peter Forsell Heart help device, method and system
US10952836B2 (en) 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women

Also Published As

Publication number Publication date
WO2004093731A2 (en) 2004-11-04
US7118525B2 (en) 2006-10-10
CA2564541A1 (en) 2004-11-04
US20040225177A1 (en) 2004-11-11
WO2004093731A3 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
US7118525B2 (en) Implantable cardiac assist device
JP4871917B2 (en) Cardiac assist system
US5222980A (en) Implantable heart-assist device
JP5918213B2 (en) Composite cardiac assist system, method and apparatus
US6616596B1 (en) Cardiac assistance systems having multiple layers of inflatable elements
US4304225A (en) Control system for body organs
US6602182B1 (en) Cardiac assistance systems having multiple fluid plenums
US6547716B1 (en) Passive cardiac restraint systems having multiple layers of inflatable elements
US9005106B2 (en) Intra-aortic electrical counterpulsation
US6540659B1 (en) Cardiac assistance systems having bi-directional pumping elements
US20040010180A1 (en) Cardiac assist system
US10507271B2 (en) Fully implantable direct myocardium assist device
US20080064917A1 (en) Amplification-Based Cardiac Assist Device
US20060074453A1 (en) Baroreflex activation and cardiac resychronization for heart failure treatment
EP1140248A2 (en) Method and apparatus for reinforcement of the heart ventricles
US20070185369A1 (en) Cardiac assist device and method
US20090177028A1 (en) Non-blood contact cardiac compression device, for augmentation of cardiac function by timed cyclic tensioning of elastic cords in an epicardial location
EP0661961B1 (en) Linear motion, muscle-actuated cardiac assist device
EP3277337B1 (en) Cardiac assist device
US20050004419A1 (en) Hydraulic assist method and system
US20180104485A1 (en) Dynamically controllable apparatus for assisting cardio-pulmonary resuscitation

Legal Events

Date Code Title Description
AS Assignment

Owner name: COLEMAN, EDWARD J., DR., WISCONSIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NEILL, WILLIAM T.;COLEMAN, GERARD T.;REEL/FRAME:019477/0168;SIGNING DATES FROM 20070606 TO 20070612

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION